Affordable Access

Publisher Website

A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy

Authors
Journal
The American Journal of Gastroenterology
0002-9270
Publisher
Nature Publishing Group
Publication Date
Volume
94
Issue
4
Identifiers
DOI: 10.1016/s0002-9270(99)00056-8
Disciplines
  • Biology
  • Medicine

Abstract

Abstract OBJECTIVE: Therapeutic options are limited for chronic hepatitis C patients who have not responded to a course of interferon therapy. Recently, a 6-month course of amantadine was shown to result in a sustained virological response in chronic hepatitis C patients who were unresponsive to interferon therapy. The aim of this study was to evaluate the effect of rimantadine on chronic hepatitis C patients who had not responded to interferon therapy. METHODS: This was an open label trial involving 17 patients who were treated with rimantadine 100 mg b.i.d. for 6 months. Changes in serum aminotransferase activities and HCV-RNA levels were determined. RESULTS: Mean alanine aminotransferase activities and HCV RNA levels did not change significantly during therapy. HCV RNA remained detectable in all patients throughout therapy. Neurologic symptoms (headaches, nervousness, and dizziness) developed in 29% of patients. A total of 12% of patients required dose reduction after 12 wk of therapy because of dizziness. CONCLUSION: Rimantadine has no significant antiviral activity against HCV.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

A pilot study of rimantadine for patients with chr...

on The American Journal of Gastro... April 1999

Treatment of chronic hepatitis C in patients unres...

on Gastroentérologie Clinique et... February 2005

Pilot study on the safety and efficacy of intraven...

on Italian journal of gastroenter... August 1997

Treatment of chronic hepatitis C in patients unres...

on Gastroentérologie Clinique et... Jan 01, 2005
More articles like this..